Mylan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.11.17	Biotech Stocks Facing FDA Decision In December (RTTNews)
20.11.17	Mylan to Present at Evercore ISI Inaugural Biopharma Catalyst/Deep Dive Conference (PR Newswire)
13.11.17	Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease (PR Newswire)
13.11.17	Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease (PR Newswire)
13.11.17	FDA Nod For BMY's Sprycel, ARNA To Report Data In Q1, MYL Delists From TASE (RTTNews)
10.11.17	Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE) (PR Newswire)
09.11.17	Mylan Launches Generic Clolar® for Injection (PR Newswire)
07.11.17	Sponsor and Exhibitor Opportunities Announced for 2018 Emerging Trends in Wellness Conference (PR Newswire)
06.11.17	Mylan-Aktie trotz Gewinnrückgangs im Plus (AWP) Der US-Generikahersteller Mylan hat erneut die zunehmende Konkurrenz auf dem US-Markt für Nachahmermittel zu spüren bekommen.» mehr
06.11.17	Mylan Lifts FY17 Earnings Outlook; Says Confident In FY18 View (RTTNews)
06.11.17	Mylan N.V. Earnings Retreat 19% In Q3 (RTTNews)
06.11.17	Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance (PR Newswire)
02.11.17	NBIX Delivers, MNTA's Biosimilar Drug Trial Fails, No FDA Panel Meet For RARE (RTTNews)
01.11.17	Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting (PR Newswire)
01.11.17	Theravance Biopharma and Mylan Report Additional Positive Phase 3 Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting (PR Newswire)
01.11.17	Momenta, Mylan Say M834 Fails To Meet Primary PK Endpoints In Phase 1 Study (RTTNews)
01.11.17	AZN Gets Speedy Nod, RBP-6000 Just One Step Away From Approval, STML Soars (RTTNews)
01.11.17	Mylan President Targeted In Generic Drug Pricing Probe (RTTNews)
28.10.17	Mylan's EpiPen4Schools® Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools (PR Newswire)
27.10.17	The WORKS, the Gourmet Burger Brand that takes burger innovation to the limit…just went even further! (PR Newswire)
26.10.17	Mylan Wins UK Court Ruling Related To Copaxone 40 Mg/mL Patent Against Teva (RTTNews)
25.10.17	CLSD Progressing With TYBEE, SNY In Legal Spat With MYL, TBPH On Watch (RTTNews)
24.10.17	Sanofi Files Suit Against Mylan To Defend Patent Rights - Quick Facts (RTTNews)
17.10.17	Mylan to Report Third Quarter 2017 Financial Results on Nov. 6, 2017 (PR Newswire)
17.10.17	Mylan Invalidates Allergan's Patents on Restasis® (PR Newswire)
05.10.17	Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone® 40 mg/mL (PR Newswire)
05.10.17	Mylan Launches First AP-rated Generic Avelox® Injection (PR Newswire)
05.10.17	Mylan Confirms U.S. Launch of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and Generic for Copaxone® 20 mg/mL Once-Daily (PR Newswire)
04.10.17	Mylan Holding On To Substantial Gain In Afternoon Trading (RTTNews)
04.10.17	MÄRKTE USA/Dow-Jones-Index setzt Rekordjagd fort (Dow Jones)
04.10.17	MÄRKTE USA/Wall Street nimmt Verschnaufpause nach Rekordjagd (Dow Jones)
04.10.17	Mylan Provides Support for U.S. Disaster-Relief Efforts (PR Newswire)
04.10.17	Gilead To License Generic Production Of Bictegravir To MPP & Four Manufacturers (RTTNews)
04.10.17	CLSN Is Hot & Newsy, CTMX Soars On AMGN Deal, SUNFISH Fails To Help PTCT Shine (RTTNews)
04.10.17	Mylan : FDA Approves First Generic For Copaxone 40 Mg/mL 3-Times-a-Week (RTTNews)
04.10.17	Mylan Announces U.S. FDA Approval of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day Exclusivity (PR Newswire)
02.10.17	Mylan Launches Generic Cancidas® for Injection (PR Newswire)
29.09.17	Mylan Launches Generic Gleevec® Tablets (PR Newswire)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
25.09.17	Indivior In Deal To Settle SUBOXONE Patent Infringement Case With Mylan (RTTNews)
19.09.17	TIBCO Connected Intelligence Cloud Equips Companies for Digital Transformation (PR Newswire)
18.09.17	Breakfast Technical Briefing on Generic Drugs Stocks -- Mallinckrodt, Horizon Pharma, Mylan, and Neurocrine Biosciences (PR Newswire)
15.09.17	Indivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent (RTTNews)
14.09.17	Mylan Expands Women's Healthcare Portfolio with Launch of Generic Minastrin® 24 FE Tablets (PR Newswire)
13.09.17	Mylan Names Dennis Zeleny as Chief Human Relations Officer (PR Newswire)
08.09.17	FDA Warns Of Manufacturing Violations To EpiPen Plant (RTTNews)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
24.08.17	Mylan Granted License To Prioritize Access To Deltyba In South Africa, India (RTTNews)
24.08.17	Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries (PR Newswire)
17.08.17	Mylan Finalizes Settlement Agreement On EpiPen Auto-Injector (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12:26		Verluste in Zürich: SMI verbucht Verluste
12:26		Optimismus in Zürich: Anleger lassen SLI mittags steigen
12:26		Montagshandel in Europa: STOXX 50 mittags mit Kursplus
12:25		Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren
10:03		SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor einem Jahr eingefahren
09:30		Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt
09:28		Gewinne in Zürich: SLI zum Start in Grün
09:28		Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus

12:26

Verluste in Zürich: SMI verbucht Verluste

12:26

Optimismus in Zürich: Anleger lassen SLI mittags steigen

12:26

Montagshandel in Europa: STOXX 50 mittags mit Kursplus

12:25

Novartis-Aktie fällt: Novartis will bei Krebskongressen zahlreiche Studiendaten präsentieren

10:03

SMI-Wert Novartis-Aktie: So viel Gewinn hätte ein Investment in Novartis von vor einem Jahr eingefahren

09:30

Novartis-Aktie: Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) gibt Hold-Bewertung bekannt

09:28

Gewinne in Zürich: SLI zum Start in Grün

09:28

Freundlicher Handel: SMI bewegt sich zum Handelsstart im Plus

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Lonza Grp	528.80	1.42 %	K V
Swiss Re	129.20	0.70 %	K V
Logitech Intl	71.28	0.37 %	K V
Part Grp Hldg	1’268.00	0.36 %	K V
Kuehne+Nagel Int	207.80	-0.81 %	K V
Givaudan	3’888.00	-1.14 %	K V
Sonova Hldg	308.00	-1.31 %	K V
Swiss Life Hldg	723.60	-1.36 %	K V
Novartis	92.21	-1.57 %	K V

Nachrichten zu Mylan N.V.

Aktien Top/Flop

Mylan Peer Group Nachrichten

Meistgelesene Nachrichten